Desai Rupak, Patel Upenkumar, Sharma Shobhit, Amin Parth, Bhuva Rushikkumar, Patel Malav S, Sharma Nitin, Shah Manan, Patel Smit, Savani Sejal, Batra Neha, Kumar Gautam
Research Coordinator, Atlanta Veterans Affairs Medical Center.
Public Health, National University.
Cureus. 2017 Nov 3;9(11):e1816. doi: 10.7759/cureus.1816.
Background Marijuana is a widely used recreational substance. Few cases have been reported of acute myocardial infarction following marijuana use. To our knowledge, this is the first ever study analyzing the lifetime odds of acute myocardial infarction (AMI) with marijuana use and the outcomes in AMI patients with versus without marijuana use. Methods We queried the 2010-2014 National Inpatient Sample (NIS) database for 11-70-year-old AMI patients. Pearson Chi-square test for categorical variables and Student T-test for continuous variables were used to compare the baseline demographic and hospital characteristics between two groups (without vs. with marijuana) of AMI patients. The univariate and multivariate analyses were used to assess and compare the clinical outcomes between two groups. We used Cochran-Armitage test to measure the trends. All statistical analyses were executed by IBM SPSS Statistics 22.0 (IBM Corp., Armonk, NY). We used weighted data to produce national estimates in our study. Results Out of 2,451,933 weighted hospitalized AMI patients, 35,771 patients with a history of marijuana and 2,416,162 patients without a history of marijuana use were identified. The AMI-marijuana group consisted more of younger, male, African American patients. The length of stay and mortality rate were lower in the AMI-marijuana group with more patients being discharged against medical advice. Multivariable analysis showed that marijuana use was a significant risk factor for AMI development when adjusted for age, sex, race (adjusted OR 1.079, 95% CI 1.065-1.093, p<0.001); adjusted for age, female, race, smoking, cocaine abuse (adjusted OR 1.041, 95% CI 1.027-1.054, p<0.001); and also when adjusted for age, female, race, payer status, smoking, cocaine abuse, amphetamine abuse and alcohol abuse (adjusted OR: 1.031, 95% CI: 1.018-1.045, p<0.001). Complications such as respiratory failure (OR 18.9, CI 15.6-23.0, p<0.001), cerebrovascular disease (OR 9.0, CI 7.0-11.7, p<0.001), cardiogenic shock (OR 6.0, CI 4.9-7.4, p<0.001), septicemia (OR 1.8, CI 1.5-2.2, p<0.001), and dysrhythmia (OR 1.8, CI 1.5-2.1, p<0.001) were independent predictors of mortality in AMI-marijuana group. Conclusion The lifetime AMI odds were increased in recreational marijuana users. Overall odds of mortality were not increased significantly in AMI-marijuana group. However, marijuana users showed higher trends of AMI prevalence and related mortality from 2010-2014. It is crucial to assess cardiovascular effects related to marijuana overuse and educate patients for the same.
大麻是一种广泛使用的消遣性物质。使用大麻后发生急性心肌梗死的病例报道较少。据我们所知,这是第一项分析使用大麻后急性心肌梗死(AMI)的终生几率以及使用大麻与未使用大麻的AMI患者的结局的研究。
我们查询了2010 - 2014年国家住院患者样本(NIS)数据库中11 - 70岁的AMI患者。使用Pearson卡方检验分析分类变量,使用Student T检验分析连续变量,以比较两组(未使用大麻与使用大麻)AMI患者的基线人口统计学和医院特征。采用单因素和多因素分析评估和比较两组的临床结局。我们使用Cochran - Armitage检验来衡量趋势。所有统计分析均由IBM SPSS Statistics 22.0(IBM公司,纽约州阿蒙克)执行。我们在研究中使用加权数据来得出全国估计值。
在2451933名加权住院的AMI患者中,识别出35771名有大麻使用史的患者和2416162名无大麻使用史的患者。使用大麻的AMI患者组中年轻男性非裔美国人较多。使用大麻的AMI患者组住院时间和死亡率较低,更多患者违反医嘱出院。多因素分析表明,在调整年龄、性别、种族后,使用大麻是AMI发生的显著危险因素(调整后的OR为1.079,95%CI为1.065 - 1.093,p < 0.001);在调整年龄、女性、种族、吸烟、可卡因滥用后(调整后的OR为1.041,95%CI为1.027 - 1.054,p < 0.001);在调整年龄、女性、种族、支付者状态、吸烟、可卡因滥用、苯丙胺滥用和酒精滥用后(调整后的OR:1.031,95%CI:1.018 - 1.045,p < 0.001)。呼吸衰竭(OR 18.9,CI 15.6 - 23.0,p < 0.001)、脑血管疾病(OR 9.0,CI 7.0 - 11.7,p < 0.001)、心源性休克(OR 6.0,CI 4.9 - 7.4,p < 0.001)、败血症(OR 1.8,CI 1.5 - 2.2,p < 0.001)和心律失常(OR 1.8,CI 1.5 - 2.1,p < 0.001)等并发症是使用大麻的AMI患者组死亡率的独立预测因素。
消遣性大麻使用者发生AMI的终生几率增加。使用大麻的AMI患者组总体死亡几率没有显著增加。然而,2段时间内使用大麻的患者AMI患病率和相关死亡率呈上升趋势。评估与大麻过度使用相关的心血管影响并对患者进行相关教育至关重要。